June 10, 2016
Article
This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
FDA Lifts Clinical Hold of Lenacapavir for HIV Treatment and Prevention
First In-Africa Clinical Trial of mRNA HIV Vaccine
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot
Estrogen Treatment Reduces Risk of COVID-19 Mortality